TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,433 | -0.6% | 38 | 0.0% | 0.00% | – |
Q2 2023 | $1,441 | -47.6% | 38 | -66.4% | 0.00% | – |
Q1 2023 | $2,748 | -61.1% | 113 | -53.5% | 0.00% | -100.0% |
Q4 2022 | $7,057 | +41.1% | 243 | +34.3% | 0.00% | 0.0% |
Q3 2022 | $5,000 | +150.0% | 181 | +182.8% | 0.00% | – |
Q2 2022 | $2,000 | 0.0% | 64 | +45.5% | 0.00% | – |
Q1 2022 | $2,000 | -92.0% | 44 | -91.3% | 0.00% | -100.0% |
Q4 2021 | $25,000 | -37.5% | 506 | -19.4% | 0.00% | -60.0% |
Q3 2021 | $40,000 | -14.9% | 628 | -3.1% | 0.01% | -9.1% |
Q2 2021 | $47,000 | 0.0% | 648 | +0.8% | 0.01% | 0.0% |
Q1 2021 | $47,000 | 0.0% | 643 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $47,000 | +571.4% | 643 | +431.4% | 0.01% | +450.0% |
Q3 2020 | $7,000 | -36.4% | 121 | -26.2% | 0.00% | -33.3% |
Q2 2020 | $11,000 | -42.1% | 164 | -46.9% | 0.00% | -57.1% |
Q1 2020 | $19,000 | +850.0% | 309 | +1445.0% | 0.01% | +600.0% |
Q4 2019 | $2,000 | 0.0% | 20 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,000 | – | 20 | – | 0.00% | – |
Q4 2018 | $0 | – | 0 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
Think Investments LP | 186,373 | $28,804,000 | 8.16% |
Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |